Željko Antić

420 total citations
8 papers, 45 citations indexed

About

Željko Antić is a scholar working on Public Health, Environmental and Occupational Health, Cancer Research and Molecular Biology. According to data from OpenAlex, Željko Antić has authored 8 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Željko Antić's work include Acute Lymphoblastic Leukemia research (7 papers), Cancer Genomics and Diagnostics (5 papers) and Genomics and Rare Diseases (2 papers). Željko Antić is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Cancer Genomics and Diagnostics (5 papers) and Genomics and Rare Diseases (2 papers). Željko Antić collaborates with scholars based in Netherlands, Germany and United States. Željko Antić's co-authors include Edwin Sonneveld, Roland P. Kuiper, Peter M. Hoogerbrugge, Simon V. van Reijmersdal, Esmé Waanders, Jiangyan Yu, Frank N. van Leeuwen, Alexander Hoischen, Martin Schrappe and Enrique Carrillo de Santa Pau and has published in prestigious journals such as Leukemia, Cancers and Haematologica.

In The Last Decade

Željko Antić

7 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Željko Antić Netherlands 5 32 23 20 16 12 8 45
Maria C. Putti Italy 5 28 0.9× 26 1.1× 26 1.3× 11 0.7× 4 0.3× 5 64
Claudia Saitta Italy 5 10 0.3× 33 1.4× 41 2.0× 7 0.4× 7 0.6× 8 70
Catherine Devoldère France 3 27 0.8× 31 1.3× 13 0.7× 9 0.6× 17 1.4× 7 68
Vesna Pavasovic United Kingdom 4 16 0.5× 14 0.6× 23 1.1× 8 0.5× 7 0.6× 8 49
Justin Engelbert United Kingdom 2 21 0.7× 18 0.8× 21 1.1× 4 0.3× 8 0.7× 2 43
Anna Maria Scattolin Italy 5 41 1.3× 44 1.9× 9 0.5× 11 0.7× 4 0.3× 10 66
Aurélie Caye‐Eude France 4 22 0.7× 21 0.9× 18 0.9× 9 0.6× 7 0.6× 8 43
Chloé Arfeuille France 5 14 0.4× 21 0.9× 16 0.8× 14 0.9× 2 0.2× 11 46
Paola Bonaccorso Italy 3 12 0.4× 14 0.6× 18 0.9× 3 0.2× 5 0.4× 11 33
Anatoly Kustanovich Belarus 4 13 0.4× 21 0.9× 19 0.9× 2 0.1× 7 0.6× 6 42

Countries citing papers authored by Željko Antić

Since Specialization
Citations

This map shows the geographic impact of Željko Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Željko Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Željko Antić more than expected).

Fields of papers citing papers by Željko Antić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Željko Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Željko Antić. The network helps show where Željko Antić may publish in the future.

Co-authorship network of co-authors of Željko Antić

This figure shows the co-authorship network connecting the top 25 collaborators of Željko Antić. A scholar is included among the top collaborators of Željko Antić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Željko Antić. Željko Antić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Antić, Željko, Stefan H. Lelieveld, Marley Yeong, et al.. (2024). Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia. Leukemia. 38(11). 2366–2375. 3 indexed citations
2.
Behrens, Yvonne Lisa, et al.. (2024). The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia. Best Practice & Research Clinical Haematology. 37(1). 101539–101539. 1 indexed citations
3.
Antić, Željko, Jana Lentes, & Anke K. Bergmann. (2023). Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology. 36(4). 101511–101511.
4.
Chouvarine, Philippe, Željko Antić, Jana Lentes, et al.. (2021). Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics. Cancers. 13(22). 5653–5653. 10 indexed citations
6.
Antić, Željko, Jiangyan Yu, Simon V. van Reijmersdal, et al.. (2020). Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations. Haematologica. 106(12). 3046–3055. 14 indexed citations
7.
Yu, Jiangyan, Esmé Waanders, Simon V. van Reijmersdal, et al.. (2020). Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia. HemaSphere. 4(1). e318–e318. 5 indexed citations
8.
Yu, Jiangyan, Željko Antić, Simon V. van Reijmersdal, et al.. (2017). Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing. Leukemia & lymphoma. 59(7). 1690–1699. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026